JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265086

Human BOD1 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

BOD1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human BOD1 knockout HeLa cell line (AB265086)
  • Sanger seq

Unknown

Sanger Sequencing - Human BOD1 knockout HeLa cell line (AB265086)

Homozygous : 1 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265086-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265086 Human BOD1 knockout HeLa cell line", "number":"AB265086-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265086-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265086-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265086-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265086 Human BOD1 knockout HeLa cell line", "number":"AB265086-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265086-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265086 Human BOD1 knockout HeLa cell line", "number":"AB265086-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265086-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265086 Human BOD1 knockout HeLa cell line", "number":"AB265086-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
BOD1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Bod1 also known as Biorientation Defective 1 is a protein with a mass of approximately 34 kDa. It is expressed in many tissues with notable presence in proliferating cells. Bod1 localizes mainly to the centrosomes and kinetochores during cell division. As a protein with important mitotic functions it contributes key mechanical roles at the cellular level ensuring proper chromosomal alignment and segregation.
Biological function summary

In regulating the mitotic spindle checkpoint Bod1 plays a significant role in securing accurate chromosome segregation. It forms part of the vital chromosomal passenger complex which includes proteins like Aurora B kinase survivin and borealin. The complex is essential for correcting improper microtubule-kinetochore attachments and achieving chromosome bi-orientation during cell division. Bod1 also assists in maintaining the structure and function of centromeres ensuring genetic stability.

Pathways

Bod1 interacts in the important processes of mitosis and spindle assembly checkpoint. It ensures correct chromosome alignment by acting in coordination with proteins such as PLK1 and Aurora B kinase which are essential for the maintenance of genomic integrity. The pathways that involve Bod1 are critical in regulating cell cycle transitions and protecting against aneuploidy a condition often arising from improper chromosome segregation.

Bod1 has been associated with certain cancers given its role in maintaining chromosomal stability. The protein's malfunction may promote aneuploidy leading to tumorigenesis. Bod1's interaction with Aurora B kinase links it to colorectal cancer where disruptions in mitotic processes play a role. Research suggests that targeting Bod1 could offer therapeutic strategies against cancers involving these mitotic dysregulations.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com